CAPRISA, UKZN & MRC Flagship - 2016-08-23Tweet
The Professional Development Programme (PDP) at CAPRISA aims to develop and retain South African scientists and professionals of the highest calibre. The genomics and bioinformatics project in HIV-1 drug resistance is inter-disciplinary in nature and involves collaboration between the CAPRISA's MRC HIV-TB Pathogenesis and Treatment Research Unit and the Flagship Program of the MRC, which are two of the most prestigious research programs in South Africa.
Prof. Tulio de Oliveira: Research Associate CAPRISA, Professor UKZN
Dr Kogie Naidoo: Head Treatment Research Programme, CAPRISA
This PhD programme optimally exemplies how genomics, clinical and bioinformatics information can directly and immediately impact human health in Africa. The project aims to identify factors associated with HIV-1 drug resistance in patients failing antiretroviral therapy (ART). By focusing on the application of Next Generation Sequencing (NGS) to produce whole genomes of the virus, researchers aim to identify new viral mutations associated with drug resistance. This could guide future drug regimens and provide further insight into patients failing ART-based therapy.
The PhD fellow will be awarded a fellowship stipend of ZAR 180,000 per annum. Applications are invited from South African or permanent resident students. Please submit a CV and a letter of motivation (max. 500 words) by 20 October 2016 to email@example.com